Clinical trials
Phase 2 Tuberculosis, Multidrug-Resistant trials in South Africa
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Global Alliance for TB Drug Development | 2 |
| Janssen Infectious Diseases BVBA | 2 |
| Boston University | 1 |
| Fundació Institut Germans Trias i Pujol | 1 |
| Gates Medical Research Institute | 1 |
| Janssen Research & Development, LLC | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis, Multidrug-Resistant | 10 |
| Tuberculosis | 7 |
| Tuberculosis, Pulmonary | 4 |
| Bacterial Infections | 1 |
| Communicable Diseases | 1 |
| Extensively Drug-Resistant Tuberculosis | 1 |
| Latent Tuberculosis | 1 |
| Mycobacterium Infections | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.